» Articles » PMID: 39941293

RL-Cervix.Net: A Hybrid Lightweight Model Integrating Reinforcement Learning for Cervical Cell Classification

Overview
Specialty Radiology
Date 2025 Feb 13
PMID 39941293
Authors
Affiliations
Soon will be listed here.
Abstract

Reinforcement learning (RL) represents a significant advancement in artificial intelligence (AI), particularly for complex sequential decision-making challenges. Its capability to iteratively refine decisions makes it ideal for applications in medicine, such as the detection of cervical cancer; a major cause of mortality among women globally. The Pap smear test, a crucial diagnostic tool for cervical cancer, benefits from enhancements in AI, facilitating the development of automated diagnostic systems that improve screening effectiveness. This research introduces RL-Cervix.Net, a hybrid model integrating RL with convolutional neural network (CNN) technologies, aimed at elevating the precision and efficiency of cervical cancer screenings. RL-Cervix.Net combines the robust ResNet-50 architecture with a reinforcement learning module tailored for the unique challenges of cytological image analysis. The model was trained and validated using three extensive public datasets to ensure its effectiveness under realistic conditions. A novel application of RL for dynamic feature refinement and adjustment based on reward functions was employed to optimize the detection capabilities of the model. The innovative integration of RL into the CNN framework allowed RL-Cervix.Net to achieve an unprecedented classification accuracy of 99.98% in identifying atypical cells indicative of cervical lesions. The model demonstrated superior accuracy and interpretability compared to existing methods, addressing variability and complexities inherent in cytological images. The RL-Cervix.Net model marks a significant breakthrough in the application of AI for medical diagnostics, particularly in the early detection of cervical cancer. By significantly improving diagnostic accuracy and efficiency, RL-Cervix.Net has the potential to enhance patient outcomes through earlier and more precise identification of the disease, ultimately contributing to reduced mortality rates and improved healthcare delivery.

References
1.
Della Fera A, Warburton A, Coursey T, Khurana S, McBride A . Persistent Human Papillomavirus Infection. Viruses. 2021; 13(2). PMC: 7923415. DOI: 10.3390/v13020321. View

2.
Cao L, Yang J, Rong Z, Li L, Xia B, You C . A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening. Med Image Anal. 2021; 73:102197. DOI: 10.1016/j.media.2021.102197. View

3.
Alsubai S, Alqahtani A, Sha M, Almadhor A, Abbas S, Mughal H . Privacy Preserved Cervical Cancer Detection Using Convolutional Neural Networks Applied to Pap Smear Images. Comput Math Methods Med. 2023; 2023:9676206. PMC: 10349677. DOI: 10.1155/2023/9676206. View

4.
Fekri-Ershad S, Ramakrishnan S . Cervical cancer diagnosis based on modified uniform local ternary patterns and feed forward multilayer network optimized by genetic algorithm. Comput Biol Med. 2022; 144:105392. DOI: 10.1016/j.compbiomed.2022.105392. View

5.
Zhao C, Shuai R, Ma L, Liu W, Wu M . Improving cervical cancer classification with imbalanced datasets combining taming transformers with T2T-ViT. Multimed Tools Appl. 2022; 81(17):24265-24300. PMC: 8933771. DOI: 10.1007/s11042-022-12670-0. View